How many patents does
Roche Palo Alto have?
patents
2,440
families
187
granted
637
applications
1,803
US
433
EP
246
CN
216
WO
111
KR
101
JP
41
RoW
1,292
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Roche Palo Alto
Top ten assignees appearing on patents
2009 - 2018
| roche | 1818 |
| roche palo alto | 357 |
| helsinn healthcare | 54 |
| pharmasset | 28 |
| roche glycart | 18 |
| maxygen | 5 |
| riboscience | 5 |
| intermune | 5 |
| gilead pharmasset | 4 |
| memory pharmaceuticals corporation | 3 |
2009
| roche | 322 |
| roche palo alto | 79 |
| helsinn healthcare | 6 |
| maxygen | 5 |
| neurogen corporation | 2 |
| astex therapeutics | 1 |
| f. hoffmann-la roche agastrazeneca | 1 |
| syntex | 1 |
| cv therapeutics | 1 |
| pharmasset | 1 |
2018
| roche | 25 |
| roche palo alto | 8 |
| helsinn healthcare | 2 |
| riboscience | 1 |
Roche Palo Alto
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| pyrrolopyrazine kinase inhibitors | 79 | 2008 |
| isoxazolo-pyridine derivatives | 59 | 2007 |
| liquid pharmaceutical formulations of palonosetron | 49 | 2003 |
| methods for improving pharmacokinetics | 40 | 2009 |
| novel pyridinones and pyridazinones | 39 | 2008 |
| novel substituted pyridin-2-ones and pyridazin-3-ones | 39 | 2008 |
| heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | 37 | 2006 |
| heterocyclic antiviral compounds | 35 | 2009 |
| diaminopyrimidines as p2x3 and p2x2/3 antagonists | 35 | 2004 |
| tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinerg… 🛈 | 31 | 2007 |